Posted in | News | Nanomedicine | Nanobusiness

Applied Nanotech Announces Resignation of CEO

Applied Nanotech Holdings, Inc. (OTCBB: APNT) today announced that Thomas F. Bijou has resigned as Chief Executive Officer, Chairman of the Board, and a member of the Board of Directors of the Company for personal reasons, effective immediately. Mr. Bijou will remain available for the next three months to assist with transition issues.

Dr. Robert Ronstadt, a member of the Board of Directors since January 2003, was elected Chairman of the Board of Directors. Dr. Ronstadt is founder of Consilience Learning, a company that currently develops and distributes software that promotes visual learning for the K-12, special needs, and higher education markets. He was formerly CEO and Chairman of Lord Publishing, a producer of financial applications software. Most recently, he was Vice President of Technology Commercialization at Boston University. Prior to that he served for five years as Director of IC2 Institute at the University of Texas at Austin, where he held the J. Marion West Chair for Constructive Capitalism.

Douglas P. Baker, the Company's Chief Financial Officer, was appointed Chief Executive Officer of the Company. Mr. Baker has been with the Company since 1996, when he was appointed CFO. During his tenure as CFO, he has been involved in virtually all aspects of the Company, including business negotiations, capital raising, strategy development, day to day operating activities, and numerous other areas.

"We are grateful to Tom for his outstanding service to the Company," said Dr. Robert Ronstadt, Chairman of the Board. "Tom's efforts have enabled us to position the Company for future growth on a profitable basis. Everyone on the Board wishes Tom the very best in his future endeavors."

'I am honored that the Board has chosen me to help guide the Company to profitability," said Douglas P. Baker. "I am excited by the significant opportunities in front of us and look forward to achieving our strategic goals in the coming months. We have more opportunities, covering a broader range of areas, than I can ever recall in my thirteen years with the Company."

Applied Nanotech Holdings, Inc. is a premier research and commercialization organization focused on solving problems at the molecular level. Its team of PhD level scientists and engineers work with companies and other organizations to solve technical impasses and create innovations that will create a competitive advantage. It also possesses investments related to electronic digitized sign technology. Applied Nanotech has over 250 patents or patents pending and its business model is to license its technology to partners that will manufacture and distribute products using the technology.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Nano Magic, LLC.. (2019, February 14). Applied Nanotech Announces Resignation of CEO. AZoNano. Retrieved on November 21, 2024 from https://www.azonano.com/news.aspx?newsID=11520.

  • MLA

    Nano Magic, LLC.. "Applied Nanotech Announces Resignation of CEO". AZoNano. 21 November 2024. <https://www.azonano.com/news.aspx?newsID=11520>.

  • Chicago

    Nano Magic, LLC.. "Applied Nanotech Announces Resignation of CEO". AZoNano. https://www.azonano.com/news.aspx?newsID=11520. (accessed November 21, 2024).

  • Harvard

    Nano Magic, LLC.. 2019. Applied Nanotech Announces Resignation of CEO. AZoNano, viewed 21 November 2024, https://www.azonano.com/news.aspx?newsID=11520.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.